Femme Homme
- | Pays :
- Ukraine
- Sweden
- Belgium
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
Primary: To assess the efficacy and safety of DVS-233 SR compared with placebo for treatment of vasomotor symptoms (VMS) associated with menopause and to compare the bleeding incidence of DVS-233 SR and tibolone. Secondary: To assess the effects of DVS-233 SR and tibolone on changes from baseline in weight, breast pain, and health outcomes indicators.
Critère d'inclusion
- Menopause